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Background: Electrospinning is a widely used technology that can produce scaffolds with
high porosity and surface area for bone regeneration. However, the small pore sizes in
electrospun scaffolds constrain cell growth and tissue-ingrowth. In this study, novel drug-
loading core-shell scaffolds were fabricated via electrospinning and freeze drying to facilitate
the repair of tibia bone defects in rabbit models.
Materials and Methods: The collagen core scaffolds were freeze-dried containing icariin
(ICA)-loaded chitosan microspheres. The shell scaffolds were electrospun using collagen,
polycaprolactone and hydroxyapatite materials to form CPH composite scaffolds with the
ones containing ICA microspheres named CPHI. The core-shell scaffolds were then cross-
linked by genipin. The morphology, microstructure, physical and mechanical properties of
the scaffolds were assessed. Rat marrow mesenchymal stem cells from the wistar rat were
cultured with the scaffolds. The cell adhesion and proliferation were analysed. Adult rabbit
models with tibial plateau defects were used to evaluate the performance of these scaffolds in
repairing the bone defects over 4 to 12 weeks.
Results: The results reveal that the novel drug-loading core-shell scaffolds were successfully
fabricated, which showed good physical and chemical properties and appropriate mechanical
properties. Furthermore, excellent cells attachment was observed on the CPHI scaffolds. The
results from radiography, micro-computed tomography, histological and immunohistochem-
ical analysis demonstrated that abundant new bones were formed on the CPHI scaffolds.
Conclusion: These new core-shell composite scaffolds have great potential for bone tissue
engineering applications and may lead to effective bone regeneration and repair.
Keywords: icariin (ICA), electrospinning, polycaprolactone, collagen 1, hydroxyapatite,
bone regeneration
Introduction
Treatment of bone defects that caused by trauma, fracture, tumour, or infection, is
still a major challenge in orthopedic practice.1 Autografts and allografts although
have been applied for many years, while it faces many disadvantages such as the
limited supply, new trauma, and risk of disease transmission.2,3 Due to the draw-
backs of the traditional therapeutic approaches, as an alternative, bone tissue
engineering (BTE) has drawn great attention as a new strategy for bone
regeneration.4,5
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The key components for BTE are scaffolds, cells and
growth factors, among which fabrication of scaffolds that
are suitable for BTE has been crucially important for cell
attachment, migration, proliferation and differentiation.6,7
Appropriate BTE scaffolds should have 1) excellent
mechanical properties to ensure the bone tissue remodel-
ling; 2) extracellular matrix (ECM) like chemical compo-
sition to facilitate cell attachment and proliferation; 3)
excellent biocompatibility and biodegradability with con-
trollable degradation and resorption rates to match the
bone regeneration; 4) appropriate porosity for cells to
attach, migrate, proliferate and deposit ECM.8
Interconnection of pores is also required to allow the
transportation of nutrients, metabolites and waste products
removal.9,10
In the past decades, various synthetic and natural poly-
mers and mineral materials have been explored as BTE
scaffolds to mimic the natural bone tissues.6,11 Bone is
made primarily of hydroxyapatite (HA) crystals inter-
spersed in a collagen (COL) matrix with HA accounting
for 70% (by weight) of human bone.12 Collagen is the
main ECM protein in the body, and has excellent biocom-
patibility, therefore has been extensively used in tissue
engineering applications. However, collagen scaffolds
themselves are limited for use in orthopedic applications
due to their poor mechanical properties.8,13 Therefore, HA/
collagen composite scaffolds have been extensively
studied.14,15 To take advantages of distinct properties of
both materials for tissue-engineering construct develop-
ment. For example, Cunniffe et al8 have recently explored
the use of nano-HA particles to fabricate the biomimetic-
inspired scaffolds through the combination of collagen. It
was found that increasing the composition of HA resulted
in the increasing of Young’s modulus of the scaffolds. The
bioactive responses, cellular attachment and osteogenesis
were enhanced. Earlier expression of bone markers and
cell-mediated mineralization were also observed.8
HA possess characterstics of high specific strength and
toughness, binders are required to glue the HA particles
and form the scaffolds with enhanced properties. Although
HA/collagen scaffolds provided better mechanical prop-
erty compared to collagen scaffolds themselves, the
mechanical property can be further enhanced by incorpor-
ating a polymer binder. Biodegradable polymers such as
poly-L-lactic Acid (PLLA), polyglycolic acid (PGA),
polylactic acid (PLA) and poly (lactic-co-glycolic) acid
(PLGA) have been widely used in BTE.16–19 However,
individual polymer cannot provide desired properties for
BTE applications. They are normally combined with HA
or other mineral materials and serve as a glue to reinforce
the mechanical property and also regulate the degradation
of the scaffolds.20 Among these polymers, PCL has better
mechanical properties and appropriate degradation rate for
bone regeneration.6,10,21 For example, using 3D printing
technology, Luo et al7 have fabricated PCL/oyster shell
powder (OSP) scaffolds for BTE. OSP particles were
found dispersed in the polymer matrix and helped to
improve the biomineralization of the scaffolds, which
also improved the proliferation and differentiation of
MG-63 cells. The addition of OSP in the scaffolds was
found enhanced the osteogenic properties and cellular
responses. Meanwhile, Shkarina et al10 have recently
explored silicate-containing hydroxyapatite (SiHA)/PCL
composite scaffolds for BTE. Increased cell viability was
observed with the SiHA/PCL composite scaffolds.
However, high hydrophobicity of the PCL leads to poor
cell attachment.7,10 ECM and growth factors are normally
required to facilitate the osteogenesis.8,10 Growth factors,
such as transforming growth factor-α (TGF-α), bone mor-
phogenetic protein (BMP), insulin like growth factor etc.,
play a vital role in bone regeneration.22–24 However, the
high cost of these growth factors limited their widespread
use, particularly in BTE practice.25–27 In order to promote
bone regeneration and repair, there is an urgent demand to
find safe and low-cost alternatives.27,28 Herba Epimedii
(HEP) is a widely used traditional Chinese herb to treat
osteoporosis in clinic.29 Icariin (ICA), the major pharma-
cologically active compound of HEP, has been used as
a potential enhancer of fracture healing, and reduce bone
losing.30–32 Therefore, ICA has a great potential as
a growth factor alternative for BTE. Based on the above,
combining PCL/collagen/HA together with addition of
ICA provides a promising solution for BTE scaffold fab-
rication with HA providing the mechanical property, col-
lagen facilitating the cell attachment and proliferation,
while the PCL bonds the HA and collagen to enhance
the mechanical property and regulate the degradation and
ICA increases the osteoconductivity.
Chitosan is not only noncytotoxic and biodegradable but it
also exhibits excellent biocompatible properties.33,34 Due to
the presence of abundant amino groups, chitosan carries
a positive charge and thus reacts with negatively charged
polymers.35 It has been reported the use of chitosan in the
formation of gels, nanoparticles, and microspheres for drug
delivery application, because of their ability for sustained
release and improved bioavailability of target molecules.36,37
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Therefore, chitosan together with the advance of nanotechnol-
ogy can be effectively applied as a carrier system for drug
delivery, which can be a better option for bone tissue
engineering.
Electrospinning is one of the widely used techniques to
produce nanofibers for various tissue engineering.38–40
Electrospun scaffolds possess high surface area to volume
ratio and high porosity which can potentially mimic the
natural ECM of bone tissues.41,42 However, the small pore
sizes in electrospun scaffolds restrain cell growth and
tissue-ingrowth, how to increase the pore sizes in electro-
spun scaffolds is a new challenge in the future.43–45
The aim of this study was to design a new kind of core-
shell scaffold is to mimic natural bone. It was hypothesized
that such type of scaffold can satisfy both of mechanical
and osteoinductive requirements for bone tissue regenera-
tion. For this purpose, the structure of the shell scaffold that
were fabricated by electrospinning with PCL/collagen/HA
is compact, which is similar to cortical bone. Meanwhile,
the core scaffolds that contained icariin (ICA)-loaded chit-
osan microspheres were fabricated by freeze-drying tech-
nologies using the combination of collagen, which can
mimic the cancellous bone (Scheme 1). It was supposed
that this kind of scaffold could improve the ability of bone
regeneration.
Materials and Methods
Preparation of ICA Loaded Microspheres
and in vitro Drug Release
To prepare the ICA loaded microspheres, 250 mg chit-
osan was dissolved in 10 mL of 2% acetic acid. The
sample was stirred using a hot plate at room temperature
for 24 h until a homogeneous solution was obtained.
After this, 40 mg ICA (Purity ≥ 99.8%, from Chinese
Institute for Drug Assay, Beijing, China) was blended
into the chitosan solution to form a homogeneous mixed
solution at room temperature. Finally, the mixed solution
was added dropwise (5 mL/h) into a 100 mL paraffine
solution containing 2% Span-80 before the addition of
25 mL (5%) tripolyphosphate solution. The sample was
being continuously stirred (450 rpm) on a hot plate until
the stable drug loaded microspheres were formed. The
supernatant was then removed through centrifugation
(2000 rpm for 30 min) and the microspheres were rinsed
for three times with ligroin and isopropanol,
Scheme 1 Schematic illustration of the fabrication process of PCL/COL/HA/ICA composite scaffold.
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respectively, before freeze-drying for 12 h. Meanwhile,
the ICA-unloaded microspheres were also prepared as
control using the same method.
For the drug release assay, a total of 30 mg of chitosan
microspheres were placed into a dialysis bag and left in
100 mL PBS (pH = 7.4, 0.01 M). The sample was incu-
bated under constant shaking at 37 °C and, 1 mL super-
natant was collected for each time at selected time scales
(1 d, 3 d, 5 d, 15 d, 20 d to 60 d), an equal volume of fresh
PBS was added. The ICA-unloaded microspheres in PBS
were also incubated at 37 °C as control. The amount of
ICA release in PBS buffer was tested by UV spectrophot-
ometer at 270 nm.
Fabrication of CPH and CPHI Composite
Scaffolds
Shell Scaffolds
To prepare the electrospun nanofibrous scaffolds, 0.3
g collagen 1 (COL1), 0.3 g polycaprolactone (PCL,
Sigma-Aldrich, USA, molecular weight, 80,000) and 0.1
g hydroxyapatite (HA) were dissolved in hexafluoroiso-
propanol (HFLP, Sigma-Aldrich, USA) to form a 3% (w/v)
to form a homogeneous solution. The electrospinning was
carried out at a voltage of 15 kV and a flow rate of 1 mL/h
using a DT −1003 electrospinning (Dalian Dingtong tech.
Ltd). The electrospun fibres were collected onto 10 mm
diameter cylinder collectors at a distance of 12 cm from
the syringe needle with the receiving shaft spinning at
530 rpm. The process was stopped when the thickness of
the electrospun shell scaffolds increased to 0.7–0.8 mm.
The samples were subsequently placed into a vacuum for
72 h at room temperature to remove HFLP solvent.
Core Scaffolds
To prepare the core scaffolds, COL1 was dissolved in 1%
glacial acetic acid to form a 4% (w/v) homogeneous solu-
tion. 10 mL solution was then mixed with 30 mg micro-
spheres, and stirred with a magnetic stirrer to form
a uniform liquid. Meanwhile, unloaded-ICA microspheres
were mixed for the fabrication as control scaffold. The
mixtures were placed into a special circular mold (dia-
meter 8 mm) then stored at −80 °C for 2 h before freeze
drying for 24 h. Finally, the core scaffolds were incubated
in 0.1% genipin (0.1 M PBS, pH = 7.4) at 37 °C for 1 h,46
After neutralization by NaOH (0.01 M) at room tempera-
ture for 30 min, the samples were washed three times
using DI water, then were dried at room temperature.
CPH and CPHI Composite Scaffolds
The core scaffold was placed into shell scaffold after they
were cut into 20 mm length respectively. The shell scaf-
folds were electrospun using collagen (COL), polycapro-
lactone (PCL), hydroxyapatite (HA) materials and the core
scaffold that incorporated the unloaded-ICA microspheres
to form CPH composite scaffolds with the ones containing
ICA microspheres named CPHI. Then the core scaffold
was placed into shell scaffold before incubated in 1%
genipin (0.1 M PBS, pH = 7.4) at 37 °C for 30 min.
After neutralization by NaOH (0.01 M) at room tempera-
ture for 30 min, the samples were washed three times
using DI water. Finally, the scaffold were obtained after
being dried at room temperature for 12 h. Each scaffold
was cut with a surgical knife blade to 5 mm in length,
sealed, and sterilized with Co-60.
Water Absorption, Porosity, Contact
Angles, and Degradation of the Scaffolds
The water-absorption capacities of scaffolds were deter-
mined by swelling the scaffolds in DI water at 37 °C. The
scaffolds (5 mm in length and 10 mm in diameter) were
separately immersed into DI water for 24 h. The water
absorption ratio was obtained with the following
equation:47
Water absorption ratio %ð Þ ¼
WHWD
WD
 100
where WH is the weight of the soaked scaffold and WD is
the weight of the dry scaffold.
The porosity of the scaffolds was measured based on
gravimetry according to the following equation:48
Porosity %ð Þ ¼
M2M3MS
M1M3D
 100
where M1 is the initial mass of a bottle filled with ethanol,
Ms is the mass of the dry scaffold, M2 is the mass of the
scaffold submerged in absolute ethanol within the bottle,
and M3 is the mass of the bottle after the scaffold was
gently removed.
Contact angles for the shell scaffold were measured
using a contact angle analyzer (FTA125, First Ten
Angstroms, Portsmouth, VA, USA). Samples of the shell
scaffold were first cut into 1 cm2 square pieces (n = 4) and
then placed on a testing plate. Subsequently, 0.03 mL of
DI water was carefully dropped onto the test sample sur-
face. After 10 second, the contact angles were recorded by
video monitor.
Zhao et al Dovepress
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For assessment of scaffold degradation, cylindrical
samples were cut into 10 mm in length. Samples were
placed into vials containing 10 mL 0.01 M PBS (pH =
7.4), and the vials were placed in a shaking water bath at
37 °C for 4–8 weeks. The PBS solution was changed
weekly. The loss in mass of the scaffold was then calcu-
lated using the following equation:49
Weight lost %ð Þ ¼
M0MD
M0
 100
where M0 is the initial weight of the scaffold and MD is the
dry weight after degradation.
FTIR Study of the Scaffolds
A total of 2 mg dried CPH or CPHI powder was mixed
with 200 mg KBr and compressed into a disk. Fourier
transform infrared spectroscopy (FTIR, AVATAR 360,
NICOLET, USA) was used to evaluate the functional
groups of the scaffolds. All spectra were obtained between
4000 and 400 cm−1 at a 4 cm−1 resolution with 32 scans.
Six samples were examined for 3 times.
Mechanical Testing
Before testing, the scaffolds were cut so that the gauge
length and diameter of all specimens were 20 mm and
10 mm, respectively. For assessment of tension strength,
the scaffolds were tested with an Instron 4505 universal
testing machine (Instron Pty Ltd., Norwood, MA, USA) at
a rate of 5 mm/second. Stress-strain graphs were then
drawn according to the load/break data.
Cell Isolation, Seeding and Proliferation
Rat marrow mesenchymal stem cells (rMSCs) were iso-
lated from femurs obtained from wistar rats by flushing
the bone marrow with PBS. The bone marrow cells were
then washed three times in PBS by centrifugation
(10 min, 250 × g). The cells obtained from rat femurs
were subsequently cultured in DMEM/F12 (D/F12), con-
tain 10% FBS and 1% antimycotic/antibiotic, in an incu-
bator at 37 °C with 5% CO2 and expanded over three
passages. The scaffolds were pre-wetted in D/F12 in 24
well plates overnight. The cells (1×106 cells/mL) were
suspended in 100 µL of D/F12 medium and seeded on
scaffolds, and subsequently cultured in six-well plates for
2 h. 2 mL medium was then added into each well and
consecutively cultured for 3, 7 and 14 d.
Scanning Electron Microscopy (SEM) and
Fluorescence Staining
The microstructure of the scaffolds and the shape of drug
microspheres were observed by SEM. At day 7, cell-
seeded scaffolds were rinsed in PBS (pH = 7.4, 0.01 M)
(n = 3), fixed in 2.5% glutaraldehyde for 48 h. Samples
were dehydrated and sputter coated with gold as common
practice for 10 min before SEM measurements. For fluor-
escence staining, the samples were dehydrated, and
embedded in paraffin before stained with 3 µM 4´,6-dia-
midino-2-phenylindole, dihydrochloride (DAPI, Sigma,
USA) for nucleus. Parallel samples were stained with
hematoxylin-eosin (H&E). The samples were observed
under a fluorescence and optical microscope (Olympus,
Tokyo, Japan), respectively.
Animal Experiment Procedures
For examination of bone regeneration, the CPH and CPHI
scaffolds were implanted into tibial plateau created in 60
male Japanese white rabbits (2 months old; weight:
1.5–2.0 kg) purchased from the Lanzhou Veterinary
Research Institute of the Chinese Academy of Agricultural
Science.
Rabbits were randomly divided into 3 groups (N = 20/
group) for control, CPH and CPHI. All animals were
anesthetized by intravenous injection of pentobarbital
sodium (0.3 mL/kg). The tibial plateau of rabbits was
exposed. The bone defect (10 mm in diameter, 5 mm in
depth) was made in the tibial plateau by an electric drill.
Bone debris was removed by physiologic saline irrigation.
The CPH and CPHI scaffolds (CPH and CPHI group)
were then implanted in the bone defect areas, respec-
tively. In the control group, no scaffolds were implanted
in the defect areas. The skin and musculature were
sutured in layers. Using iodine wiped suture and marked.
To prevent postoperative infections, penicillin injections
(400k units) were administered once a day for 7 days. The
general conditions of the rabbits (diet, activity, energy,
and wound healing) were continuously monitored for
2 weeks.
Radiographic and Three-Dimensional CT
Scanning
X-ray and three-dimensional CT were performed to analyse
bone regeneration and reconstruction conditions. Rabbits
(n = 3) from each group were anesthetized by pentobarbital
at 4, 8, 12 weeks post-operation, respectively. The bone
Dovepress Zhao et al
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defect areas were examined by X-ray and three-dimensional
CT reconstruction scanning.
Micro-CT Scanning and Quantitative
Analysis
After radiographic examination, the rabbits were anesthe-
tized with an overdose of pentobarbital. The soft tissues
attached to the bone defect were gently removed and the
tibias were harvested and fixed in 10% formaldehyde for
48 h. The samples were scanned with high-resolution (12
µm) micro-CT (GE Healthcare, USA) and a 3D image was
reconstructed before the measurement of the bone mineral
density of new bone. 3 rabbits in each group were mea-
sured for three times, and the amount of bone regeneration
was calculated based on the average value.
Histological Staining
20 mm bone tissue samples were collected from the tibia
in each group, fixed in 10% formaldehyde for 72 h and
subsequently decalcified in 5% EDTA-Na2 (pH = 7.0) for
5 weeks at room temperature. After complete decalcifica-
tion, the samples were dehydrated, and embedded in par-
affin. Hematoxylin and eosin (H&E) staining and Masson
trichrome staining were employed to analyse bone regen-
eration and scaffold degradation at bone defect areas. All
histological images were photographed digitally with
a microscope and analyzed with a digital image analysis
system (DXM 1200, Nikon, Japan).
Immunohistochemical Staining
Samples were deparaffinized in ascending ethanol, then
rehydrated by boiling in sodium citrate solution for 10
min. The immunohistochemical assay was performed fol-
lowing the protocols provided by the manual of the kit.
Sections were reacted with the primary antibodies: mouse
monoclonal alkaliphosphatase (ALP) antibody (1:500, over-
night at 4 °C; Abcam, USA), rabbit monoclonal type
I collagen (Col I), rabbit monoclonal osteocalcin (OCN)
antibody (1:500, overnight, 4 °C; Abcam, USA) and rabbit
monoclonal osteopontin (OPN) antibody (1:500, overnight,
4 °C; Abcam, USA). The biotinylated secondary antibody
(1:1000, 37 °C, either goat anti-mouse or anti-rabbit) was
applied for 30 min. Sections were stained with 3,3ʹ-
diaminobenzidine tetrahydrochloride (DAB, sigma, USA),
rinsed with PBS (pH = 7.4, 0.02 M), dehydrated, and
examined with a microscope (Olympus). All histological
and immunohistochemical images were photographed
digitally with a CCD camera and analyzed with a digital
image analysis system (DXM 1200, Nikon, Japan).
Animal Study Approval
All animal studies were performed in compliance with the
regulations and guidelines of the Orthopedics department
and approved by China’s Animal Research Authority and
Ethics Committee of the General Hospital of Lanzhou
Military Command of the PLA. Animal care was con-
ducted according to the Association for Assessment and
Accreditation of Laboratory Animal Care international
(AAALAC) and Institutional Animal Care and Use
Committee (IACUC) guidelines.
Statistical Analyses
All data are presented as means ± standard deviations.
A two-tailed unpaired Student’s t-test was used to assess
for significant differences between groups; P value < 0.05
was considered statistically significant. SPSS 13.0 statisti-
cal software (SPSS, USA) was used to analyze all data.
Results
Scaffold Characterization
The morphology of the fabricated scaffolds were observed
by scanning electron microscopy (SEM) as shown in
(Figure 1A2-3 and B2-3). The shell scaffolds produced
by electrospinning displayed three-dimensional network
structure with high porosity. The mean diameters of the
fibres in the uncross-linked scaffolds are in the range from
100 to 700 nm (Figure 1A2). However, when the scaffolds
were cross-linked by genipin, the fibres diameters
increased from 100–700 nm to 300–1000 nm
(Figure 1B2). The surface of the fibres also became
rough compared to the control group. The morphology of
the core scaffolds were also observed by SEM. It was
found that the microstructure of the uncross-linked core
scaffolds was characterized by smooth surface topography
(Figure 1A3). After cross-linking by genipin, the surface
morphology was switched to be rough and compact.
However the pore sizes and the number of pores were
not significantly reduced in comparison with the uncross-
linked scaffolds (Figure 1D).
The water absorption measurement of the scaffolds is
shown in Figure 1C. It was found that uncross-linked scaf-
folds have a water absorption ratio of 48.6%. However, after
cross-linking with genipin, the water absorption was reduced
to 39.5%, indicating the decrease of the water absorption
Zhao et al Dovepress
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after genipin cross-linking. As shown in Figure 1D, the
porosity for the scaffold was 76.3% and 74.8% for the cross-
linked scaffolds ones and uncross-linked scaffolds ones,
respectively. Therefore, no significant difference between
the two types of scaffolds was found. The degradation rate
of the scaffolds that soaked in PBS for 8 weeks was 32.98%
for the cross-linked scaffolds and 70.06% for the uncross-
linked scaffolds (Figure 1E), indicating that the cross-linking
has a significant effect to the degradability.
Figure 1F shows the compressive strength of the scaf-
folds. The average maximum load for the scaffolds were
72.8±1.3 N for the cross-linked scaffolds, and 42.3±1.7
N for the uncross-linked scaffolds, showing that the
mechanical strength of the cross-linked scaffolds were
remarkably increased compared to the uncross-linked
scaffolds.
To investigate the cross-linking, FTIR has been
employed with the data shown in Figure 1G. The spectro-
scopic analysis confirmed the formation of cross-linking
through the addition of genipin, reflected by the emergence
of the desired bands at their respective positions. For the
uncross-linked shell, the band at 564 cm−1 represents the
P-O bending vibration; the bands at 1040 cm−1 and
1092 cm−1 represent HA stretching vibrations; the band at
Figure 1 Surface topography and physical properties of the CPH scaffolds. (A1) The gross appearance of the uncross-linked scaffolds. (A2–A3) Scanning electron
microscopy images of the uncross-linked scaffolds. (B1) The gross appearance of the cross-linked scaffolds. (B2–B3) Surface topography of the cross-linked scaffolds. (C)
Water absorption ratios. (D)Porosity. (E) Loss weight; and mechanical property (F) of the scaffolds with and without cross-
linking. (G) Spectra of the CPHI scaffolds with and without cross-linking. (H) Characterization of the hydroxyapatite (HA)-incorporated scaffolds. The results are presented
as the mean ± standard deviations (n = 3). * p < 0.05; ** p < 0.01; * is the significance compared to the uncross-linked scaffolds.
Abbreviation: HA, hydroxyapatite.
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1660 cm−1 represents the C=O stretching vibration; the band
at 1456 cm−1 represents the N-H absorption; the bands at
1730–1737 cm−1 represent the C=O stretching vibrations.
The presence of these bands further confirms that HA, PCL
and Col were successfully blended in the composite materi-
als. In comparison, for the cross-linked shell, the band at
1103 cm−1 represents the C-O-C stretching vibrations and
the band at 733 cm−1 represents the N-H bending vibration,
The absorbance band at 1104 cm−1 and 1370 cm−1 signifi-
cantly increased (Figure 1G), indicating that collagen was
cross-linked with genipin.50
Figure 1H shows the chemical composition of CPH
scaffold. Strong signals were detected for Ca, and P, indi-
cating the existence of HA-incorporated in the scaffold.
Microspheres Characterization,
Distributed and ICA Release Kinetics of
Scaffolds
We employed the chitosan to form micro-particles for the
ICA drug loading and release. The chitosan microspheres
were prepared as described in section 2.1 with the morphol-
ogies of chitosan microspheres shown in Figure 2A. The
microspheres showed spherical shape with smooth surface
and no aggregation was observed. The particle sizes of
microspheres were between 1–5 µm. The cumulative
release of ICA from the microspheres was measured and
shown in Figure 2B. The resulting release curve exhibited
a increased at 5 d, at which time 30% of the total amount of
ICA had been released from microspheres. From 10 d, ICA
release was significantly increased. Stable release was
maintained such that 70% of the loaded ICA had been
released by 20 to 60 d.
Figure 2C shows the SEM images of core scaffold that
without incorporation of microspheres. The microspheres
distribution in the core scaffolds is showed in Figure 2D. It
was found that the microspheres evenly distributed in the core
scaffolds, ensuring the stably release of ICA from the micro-
spheres with the degradation process of the core scaffolds.
Cell Morphology
To investigate the cell attachment behaviour, rMSCs were
cultured on the shell and core scaffolds for 7 days, respec-
tively. Figure 3A shows the SEM and histological staining
images of the rMSCs on the shell scaffolds after being
cultured for 7 days. The cells stretched along the surfaces
of the shell scaffolds to form a well attached cell layer
(Figure 3A1-A3). Cell morphology on the core scaffolds
Figure 2 Characterization of microspheres, cumulative release of ICA and distribution. (A) Scanning electron microscopy images of the ICA loaded chitosan microspheres.
(B) The curve of ICA released from the microspheres. (C) and (D) The scaffolds scanning electron microscopy images of the core scaffold, (C) without the chitosan
microspheres, (D) with the chitosan microspheres. The results are presented as the mean ± standard deviations (n = 3). Red arrow: chitosan microspheres.
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after being cultured for 7 days is shown in Figure 3B1-B3.
It was clearly found that the fusiform cells with parapo-
dium attached on the surface of the core scaffolds.
Fluorescence staining also confirmed nice cell attachment
and proliferation on the shell and core scaffolds
(Figure 3A4-6 and 3B4-6).
General Observations, X-Ray and CT
Images for the Monitoring of Bone
Formation
Tibial plateau bone defects in rabbits treated with dif-
ferent scaffold materials before and after 4–12 weeks of
implantation are shown in Figure 4A1-3 (defect control)
and 4B1-6 (CPH and CPHI). The results showed the
area of bone defects in the CPHI scaffold group was
significantly decreased in comparison to the CPH scaf-
fold and defect control. The defect area in A3 was
covered by connective tissue rather than the new bone
tissue. This was confirmed by the H&E staining shown
in Figure 6.
X-ray examination results are shown in Figure 4C. At 4
weeks after surgery, low density bone regeneration was not
observed in the bone defect areas. By week 8, some high-
density bone regeneration was observed in the bone defect
areas in the CPH group (Figure 4C5). However, new bone
formation was detected in the defect centre in the CPHI
group (Figure 4C8). By 12 weeks, more high-density bone
regeneration was observed in the defect site treated with
the CPHI scaffolds (Figure 4C9) than that treated with the
CPH composite scaffolds (Figure 4C6), indicating the for-
mation and progression of newly formed bone towards the
defect centre from peripheral edges in CPHI groups.
Three-dimensional CT reconstruction was performed
for bone defects in the tibial plateau after 4–12 weeks of
implantation as shown in Figure 4D1-9. The reconstructed
3D CT images directly showed newly formed bone in the
defect areas. After 12 weeks of implantation, more newly
Figure 3 Adhesion and proliferation of rMSCs on the shell and core scaffolds. (A) Cell adhesion and proliferation on the shell scaffolds were demonstrated by SEM (A1 and
A2), hematoxylin and eosin (H&E) staining (A3) and fluorescence staining (A4–A6). (B) Cell adhesion and proliferation on the core scaffolds were demonstrated by SEM
(B1 and B2), H&E staining (B3) and fluorescence staining (B4–B6). Blue = DAPI staining for Nucleus. Red = scaffold (autofluorescence of genipin). Red arrows: cells. Scale
bar = 100 µm.
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formed bone was observed in the area where CPHI com-
posite scaffolds were implanted compared to that of CPH
scaffolds (Figure 4D9).
Quantification of New Bone Formation
(Micro-CT Scan)
Bone mineral density (BMD) and connective density
(Conn.Dn) are two principal parameters for evaluating
the new bone quality. The micro-CT scan was performed
to quantify the new bone formation with the data shown
in Figure 5. At 4 weeks, a small amount of bone-like
tissue was observed within the bone defect areas (in the
red circles) in the CPHI and CPH scaffold groups
(Figure 5A). However, the levels of BMD (around
150 mg/cc) and Conn.Dn (less than 3.66/mm3) was very
low for all groups and also very similar between groups.
By 8 weeks, bone-like tissue was observed in the CPHI
and CPH groups, only accounting for 1.5±1.3% of the
bone defect area in CPH group. However, BMD and
Conn.Dn were markedly increased in the CPHI
groups in comparison to the CPH and control groups
(Figure 5A–C). At 12 weeks, more new bone formation
was observed (Figure 5A) in CPHI scaffold group, evi-
denced by the micro-CT images and the 3D reconstruc-
tion (orange color in the right column in Figure 5A). The
BMD was found around 369.9±39.67 mg/cc at 12 weeks
for the CPHI group, much higher than that of CPH group
(299.1±45.32 mg/cc) and control group (166.5±29.3 mg/
cc) (Figure 5B). The Conn.Dn of the CPHI group (43.5
±3.76%) at week 12 was also found significantly higher
than that of CPH group (26.0±3.66%) and the control
group (10.5±2.43%) (Figure 5C). These results demon-
strate that CPHI scaffolds are significantly better than that
of the CPH scaffolds.
New Bone Formation Assessed by
Histologic Analysis
H&E staining of bone defect sites treated with CPH and
CPHI composite scaffolds was carried out to evaluate
their suitability as osteoinductive materials. After 4
weeks, the core of the CPHI scaffolds were filled with
osteoblasts, bone matrix and immunocyte in the defect
areas. Whereas, immunocyte and fibroblasts were domi-
nating filled in the CPH scaffolds and defect groups
(Figure 6A and C). By 8 weeks, new bone formation
was observed and many osteoblasts appeared along with
the new bone in the core of CPH and CPHI scaffolds,
meanwhile, the newly-formed bone tissue were also found
in the shell of the CPHI scaffolds. However, more fibrous
tissue had been found in the control group (Figure 6A
and C). At 12 weeks after implantation, larger amounts of
bone tissue around the scaffolds and in the core scaffolds
Figure 4 Implantation procedure, X-ray and 3D reconstruction analysis of new bone. (A) Photographs showing the surgical implantation procedure (A1 and A2) of the
CPH, and CPHI scaffolds in rabbit bone defects. (A3) shows the defect control covered by the connective tissue after 12 weeks. (B1–B6) New bone formation of CPH and
CPHI groups after 4, 8, and 12 weeks. (C1–C9) Evaluation of in vivo bone formation: representative X-ray images showing the level of the regenerated bone tissue after
4–12 weeks. (D1–D9) 3D reconstruction images showed the different reparative effects of the CPH and CPHI scaffolds after 4–12 weeks. Red arrows: bone density, Red
dotted circles: defect areas, Red arrow: density bone regeneration.
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were observed in the CPHI scaffold group. The shell
scaffolds were also found partly degraded (Figure 6A
and C).
Masson staining is shown in Figure 6B. In the fourth
week, many regions had no observable bone formation in
all the groups. In contrast, the core of the CPHI scaffolds
were filled with fibrous tissue (blue) in the defect areas. By
8 weeks, it can be found from Figure 6B and D, large
numbers of osteocytes were located in the core of the
scaffolds in both of the CPH and CPHI groups.
Meanwhile, mature bone tissues were also observed in
the CPHI group. In contrast, the fibrous tissue filled the
bone defect area of the control group at 12 weeks after
implantation. In the CPHI group, abundant new bone for-
mation was seen at 12 weeks after scaffold implantation.
A similar regeneration process was observed, but only thin
trabecular bone formed in the centre of the CPH scaffolds
(Figure 6B and D).
Immunohistochemical Assessment
To investigate the levels of expression of alkaline phos-
phatase (ALP), type I collagen (COL1), osteocalcin (OC),
and osteopontin (OPN), immunohistochemical staining
was performed and shown in Figure 7. Four weeks after
implantation, lower expression levels of COL1, OC, and
OPN was observed in the CPHI group. However, positive
expression of ALP was not observed. After 8 weeks, the
expression of ALP, COL1, OPN and OC had markedly
increased in the CPHI group, whereas low expression of
ALP, COLI, OPN, and OC was detected in the CPH group,
indicating the presence of cartilage tissue within the CPHI
scaffolds. For both CPHI and CPH scaffold groups, the
Figure 5 Micro-CT analysis of new bone. (A) Micro-CT scan images showing the level of regenerated bone tissue after 4–12 weeks. (B) Bone mineral density (BMD) of the
regenerated bone tissue after 4–12 weeks. (C) Tissue connective density (Conn.Dn) of the regenerated bone tissue after 4–12 weeks. Data display the mean relative values
calculated from three independent experiments (mean ± SD). * p < 0.05; ** p < 0.01; * is the significance compared to defect control, #is the significance compared to 8
weeks. Red dotted circles: defect areas.
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intensity of positive staining for COL1, OPN, and OC
increased with time and the expression was mainly seen
in the new bone. However, the expression levels of these
proteins in the CPH group were much less than that in the
CPHI groups (Figure 7A–H).
Discussion
In this study, we fabricated the core-shell composite scaf-
folds with ICA-loaded chitosan microspheres incorporated
into collagen 1 as core scaffolds and polycaprolactone/
collagen/hydroxyapatite (CPH) composite was used to
prepare the shell scaffolds by electrospinning (Figure 1A
and B). Our aim is to evaluate whether this new-type of
scaffolds can remarkably promote bone regeneration.
Previous study showed that ICA not only can induce
MSCs to differentiate into osteoblasts but also promote
osteogenesis,51,52 meanwhile, Xie et al30 studied the effect
of ICA-SF/PLCL nanofibrous membrane by coaxial elec-
trospinning on bone regeneration. The results showed that
ICA-SF/PLCL nanofibrous membrane can promote bone
regeneration. Zhang et al53 also reported that the calci-
nated antler cancellous bone (CACB) scaffolds with ICA,
not only increased osteogenic gene expression, mineraliza-
tion of rat bone marrow mesenchymal stem cells but also
promoted the osteogenesis and neovascularization both
in vitro and in vivo. All these results indicated that ICA
as a bioactive factor has a potential value for BTE.
However, the use of ICA in scaffolds for bone regenera-
tion has not been well studied. MSCs homing is an incho-
ate event in the injured tissue. ICA plays an important role
in MSCs homing, which is a vital mechanism of tissue
regeneration.54 Based on these factors, we fabricated
Figure 6 Histological staining assessment of the newly formed bone at 4–12 weeks post implantation of CPH and CPHI scaffolds in rabbit bone defects. (A) Staining with
haematoxylin and eosin (H&E) demonstrates new bone formed in the CPH and CPHI scaffolds. (B) Masson’s trichrome shows matrix distribution (scale bar = 100 µm). (C)
and (D) Show the quantitative data from (A) and (B), respectively. Data display the mean relative values calculated from three independent experiments (mean ± SD). * p <
0.05; ** p < 0.01; *** p < 0.001; * is the significance compared to defect control, # p < 0.05; is the significance compared to CPH group.
Abbreviations: NB, new bone; M, implanted material; HB, host bone; F, fibrous tissue.
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a new core-shell scaffold that not only release ICA in early
stage of bone regeneration, but also maintained new bone
formation.
An Ideal scaffold for bone repair should be able to
mimic the natural extracellular matrix.55,56 In this study,
we chose type 1 collagen, HA and PCL as the main
Figure 7 Immunohistochemistry staining for (A) alkaline phosphatase (ALP), (C) type I collagen (COL1), (E) osteocalcin (OC), and (G) osteopontin (OPN) of bone defects
at 4–12 weeks post implantation in rabbits. (B), (D), (F), and (H) Show the quantitative data from (A), (C), (E), and (G), respectively. Data display the mean relative values
calculated from three independent experiments (mean ± SD). * p < 0.05; ** p < 0.01; * is the significance compared to defect control, # p < 0.05; is the significance compared
to CPH group. Scale bar = 100 µm.
Abbreviations: NB, new bone; F, fibrous tissue.
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components for electrospinning to fabricate the shell of the
composite scaffolds (Figure 1A and B). This is because
type 1 collagen is one of the main components of bone and
also has excellent biocompatibility with no toxicity and no
immunogenicity. It can also support and protect cells, and
mediate cell adhesion.57 PCL is a resorbable polymer that
has a much lower rate of degradation and excellent
mechanical properties.58 HA is also a main natural com-
ponent of bone, which had been applied in BTE for long
time.59,60 For example, Fu et al61 fabricated the composite
scaffold composed of poly(ε-caprolactone)-poly(ethylene
glycol)-poly(ε-caprolactone) (PCL-PEG-PCL, PCEC) and
30 wt.% nano-hydroxyapatite (n-HA) through electrospin-
ning, and showed excellent activity in guiding bone regen-
eration. Several investigators have developed the
electrospun PCL/COL/HA scaffolds in promoting bone
regeneration. For example, Phipps MC. Fabricated the
scaffolds composed of blended PCL/collagen
I nanofibers, and nanoparticles of HA, promoted greater
mesenchymal stem cell (MSC) adhesion, and proliferation,
as compared with scaffolds composed of PCL alone.62
Therefore, the PCL/COL/HA scaffolds have potential uti-
lity as a substrates for supporting cell expanded and tissue
regeneration. Based on electrospun scaffolds have nanofi-
brous structure, large surface to volume ratio, and inter-
connecting pores, therefore, its has potential utility in bone
repair. However, the small pore sizes in electrospun scaf-
folds constrain cell growth and tissue-ingrowth. In order to
overcome this drawback, several strategies have been
developed for increasing the average pore size of the
electrospun scaffolds. Pham et al resolved this issue by
decreasing layers of nanofibers.63 Others reported that the
electrospun scaffolds were fabricated by salt leaching64 or
cryogenic electrospinning.65 Some investigators have
explored co-electrospinning sacrificial fibers along with
stable fibers, the larger pores were created when the sacri-
ficial fibers removed, the cells successful infiltrated in the
scaffold.66 Core-shell structured nanofibers as a promising
material were fabricated by the coaxial electrospinning
technique, which could promote osteoblast cell growth in
bone tissue engineering.67 However, the key problem of
these strategies is the pores sizes not adequate to enhance
cellular infiltration. Therefore, it is tickler for the electro-
spun scaffolds that how to mimic native bone increase
bone tissue regeneration.
In this study, a new strategy was employed to construct
shell scaffold using PCL/COL/HA materials through elec-
trospinning. Meanwhile, the amount of HA was gradually
increased from interior to outer layer of the shell scaffolds,
which mimic the natural cortical bone structure. On the
other hand, ICA-loaded microspheres were incorporated
into the core scaffold. Due to the easy degradation of
collagen, ICA can rapidly release in the early stage and
plays its role in early bone regeneration (Figure 2B).
The mechanical strength of the scaffold plays a crucial
role in BTE.68,69 In order to increase the mechanical strength
of the scaffolds, we employed genipin as a cross-linking
agent to treat the core-shell scaffolds. Mechanical strength
of the scaffolds was remarkably increased after scaffolds
were cross-linked70 (Figure 1F). Meanwhile, the degradation
rate of the scaffold was decreased (Figure 1E). Degradation
speed of the scaffold is one of the important factors for BTE.
Fast degradation of the scaffold results in the lack of mechan-
ical support during the new tissue forming, while slow
degradation of the scaffold results in the inflammatory
response, impairing new tissue regeneration.71 Therefore,
controlled biodegradability is essential for the scaffolds in
BTE. Our results showed that the degradation behaviour of
the cross-linked scaffolds was significantly decreased in
comparison with the uncross-linked scaffolds, providing
a controlled biodegradability suitable for bone defect regen-
eration (Figure 1E).
Pore sizes are important for BTE scaffolds and has
been shown to affect the progression of osteogenesis.72
Small pore size (< 100 µm) not only reduce cell migration
but also restrict nutrient delivery and waste removal.
Additionally, it also limit the amount of new tissue
regeneration.72 It has been reported that pore size > 100
µm with gradients are recommended.73,74 We had fabri-
cated the core-shell CPH and CPHI scaffolds by electro-
spinning and freeze drying with a gradient in pore sizes to
facilitate the repair of tibia bone defects in rabbit models.
SEM images confirmed the gradients of pore sizes in
scaffolds (Figure 2A and B). The active ingrowth of
bone inside the scaffolds can be attributed to the fully
interconnected pores (Figure 3). The radiography, micro-
CT, H&E and Masson staining results indicate that the
amount of bone formation in the CPHI group was mark-
edly higher than those in other groups. The formation of
new bone can also increase collagen synthesis and miner-
alization in the period of bone regeneration (Figures 4–6).
The results demonstrated that both CPH and CPHI scaf-
folds provided adequate pores for cellular attachment and
proliferation in vivo.
Immunohistochemistry results showed that the biomar-
kers of osteogenesis, including ALP, COL1, OCN and
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OPN, were markedly increased in the CPHI group com-
pared with the CPH group for weeks 8 and 12 (Figure 7).
This indicates that the sustained release of ICA from CPHI
scaffolds remarkably promoted new bone formation with-
out adverse effects. These results indicate that the CPHI
scaffolds have excellent osteoinductivity and osteoconduc-
tivity. The distinct features of the scaffolds may explain
this superior therapeutic efficacy: Firstly, since the core
scaffolds were loaded with ICA and shell scaffolds were
combined with HA, excellent osteoinductivity was
achieved due to the synergistic effect of ICA and HA on
increasing bone tissue regeneration.75 Secondly, the highly
ordered channel structure with gradients of pore sizes
provided a suitable space for local bone remodelling
initiated by stimulating the proliferation of osteoblasts
and recruiting osteoprogenitors to defect location.76
Finally, the degradation rate of CPH scaffold nicely
matches the bone formation rate at the defect site,77 ensur-
ing the scaffold degradation give way to newly secreted
bone matrix and sequential mineralization.
Conclusion
In this study, two types of scaffolds (CPH and CPHI)
were fabricated through electrospinning and freeze-
drying technologies and implanted into rabbits for up to
12 weeks. ICA was loaded into the core scaffolds to form
the CPHI scaffolds. X-ray, micro-CT, histological, and
histochemical methods were employed to study the bone
regeneration processes. X-ray image showed changes of
the lamina bony defect over time. In the CPH scaffolds
group, the bony defect was not completely filled even at
week 12 due to the lack of new bone formation. On the
other hand, at both weeks 8 and 12, the bony defects in
the CPHI scaffolds group were filled with a bone mass
with the progression of the new bone formation being
clearly seen from the X-ray images at weeks 8 and 12.
Much denser bone with better lamina reconstruction was
observed. Meanwhile, the bone formation of the CPHI
and CPH groups was also analysed by histological
method with H&E and Masson staining. There was no
noticeable new bone formation inside the scaffolds of the
control and CPH groups at week 4. On the other hand,
active new bone formation was observed around the
scaffold and even in the centre of the CPHI group.
Little new bone formation was observed in the scaffolds
area in CPH group at week 8. Whereas in CPHI group,
a substantial amount of new bone was observed in the
interface between the ulna and radius. Ingrowth of new
bone inside the scaffolds was also found. At week 12,
calcified and matured new bone that infiltrated into the
scaffolds was observed in both CPH and CPHI groups.
However, CPHI scaffolds were found more effective than
CPH scaffolds in inducing bone regeneration. This was
due to the fact that ICA release from CPHI increased cell
growth and differentiation, together with the synergetic
effect of HA, making the scaffolds more osteoinductive
than CPH scaffolds. These results suggested that CPHI
scaffolds have great potential for the induction of bone
regeneration and application in tissue engineering of
bone defects repair.
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